WASHINGTON (AP) — Federal health experts say a diabetes drug from Novo Nordisk should be approved for a new use in treating obesity. The panel of Food and Drug Administration advisers voted 14-1 that the injectable drug’s benefits outweigh it risks for patients who are obese or dangerously overweight. The FDA first approved the […]
Join the fight for freedom
Be the first to know: Stories from The Washington Informer in your inbox each weekday.